ArticleTherapeutic advances in medical oncology2025

Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium.

Musa Barış Aykan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.